-
Illinois to probe drugmaker after it laid off hundreds
Illinois plans to investigate Akorn Operating Co. after the drugmaker laid off hundreds of workers in late February, according to The Center Square. -
Walgreens reverses plan to dispense abortion pills in some states
Walgreens will not dispense abortion pills in several states where they remain legal. The move comes in response to pressure from Republican attorneys general, who last month wrote a letter to the company threatening legal action if it begins dispensing the drugs, Politico reported March 3. -
Walgreens partners with DoorDash, Uber for fast HIV prescription delivery
Transportation has been cited as a persistent barrier to healthcare access for many across the U.S. In an effort to curb that, a new partnership between Walgreens, DoorDash and Uber will now offer same-day delivery of HIV drugs to any patient within 15 miles of the pharmacy. -
4 drugmakers short on methotrexate amid post-Roe restrictions
Nationwide shortages of rheumatoid arthritis drug methotrexate, which some pharmacies have restricted because it can cause pregnancy complications or miscarriage, continue as four prominent pharmaceutical companies report shortages. -
Before its fall, Akorn settled a lawsuit for $7.9M
Akorn Operating Co., a Gurnee, Ill.-based drugmaker that shut down in late February after years of manufacturing violations and dwindling finances, settled for $7.9 million in a lawsuit involving Medicare false claim allegations. -
Some pharmacies don't carry Ozempic — but not because of the shortage
Independent pharmacies across the country have stopped stocking diabetes drug Ozempic, a popular off-label weight loss aid, but not because of the ongoing shortages, NBC News reported March 2. -
Hard to swallow? An FDA-approved capsule that tracks, sends data
The FDA recently greenlit an Irish devicemaker's request to market its Pill Sense System, an ingestible capsule that winds its way through a patient's gastrointestinal tract, detects light wavelengths and wirelessly transmits data. -
Hospitals' albuterol supply may dip after drugmaker shuts down
After Gurnee, Ill.-based Akorn Operating Co. closed its operations in late February, hospitals are left with only one domestic supplier of liquid albuterol, an asthma treatment already in shortage. -
Eli Lilly caps insulin at $35 a month
Effective immediately, Eli Lilly is capping out-of-pocket costs on its insulin products at $35 a month. The price cap automatically applies to people with private insurance. Uninsured individuals who sign up for Eli Lilly's insulin value savings program are also eligible. -
6 numbers on pharmacy techs
Here are six statistics about health system pharmacy technicians, according to survey data the Pharmacy Technician Certification Board collected in May. -
4 new drugs to watch, per Optum
OptumRx, a UnitedHealth Group subsidiary, is eyeing four new drugs this year: -
UF Health launches pharmacogenetics tool for patients
A service launched by University of Florida Health in Gainesville is designed to assist patients in interpreting pharmacogenetic test results. -
Mark Cuban's pharmacy racks up 2 million customers in 13 months
A little over a year since the online pharmacy launched in January 2022, Mark Cuban Cost Plus Drug Co. has served 2 million customers. -
Dr. Billy Dunn, FDA leader tied to Aduhelm approval, departs
Billy Dunn, MD, director of the FDA's neuroscience division, left the agency on Feb. 27. Dr. Dunn was part of the cohort that defended Aduhelm, an Alzheimer's drug whose approval has been highly criticized. -
Pfizer to acquire cancer drugmaker Seagen
Pfizer said March 13 it will acquire Seagen, a cancer therapeutics company, for $43 billion. -
Physician group touts ivermectin as flu, RSV treatment — but it's unproven
A group of physicians that promoted ivermectin as a COVID-19 medication, which was disregarded, is now touting the drug as a treatment for influenza and respiratory syncytial virus despite a lack of evidence, The Washington Post reported Feb. 26. -
OSF Healthcare pharmacist saves life in airport
Pharmacist Lauren Kirkpatrick, PharmD, was in an airport about to fly to San Francisco when she heard someone a few gates away yell, "Does anyone know CPR?" the Commercial-News reported Feb. 25. -
Feds to restrict some telehealth prescriptions for ADHD drugs, painkillers
The Biden administration and the Drug Enforcement Administration said physicians will no longer be able to prescribe some medications via telehealth without meeting the patient in person first, CBS News reported Feb. 27. -
Cities where Ozempic prescriptions have risen the most
There's a nationwide shortage of diabetes management drug Ozempic, but some cities far outpace the rest when it comes to how many prescriptions of the drug are being written. -
Moderna pays NIH $400M in COVID-19 vaccine licensing fees
Moderna has paid the National Institutes of Health $400 million in licensing fees for a chemical technique developed by federal researchers that was used to create its COVID-19 vaccine, the company said in a Feb. 23 earnings report.
Page 50 of 50